TORRENT PHARMA INC — Pantoprazole Importer Profile
Pharmaceutical Importer · #9 buyer for Pantoprazole · $9.7M import value · 276 shipments · UNITED STATES · DGFT Verified
TORRENT PHARMA INC is the #9 importer of Pantoprazole from India with $9.7M in import value and 276 verified shipments. TORRENT PHARMA INC holds a 0.6% market share in Pantoprazole imports based in UNITED STATES. The company sources from 1 verified supplier across 112 formulations shipped to 1 country. Overall, TORRENT PHARMA INC imports 9 pharmaceutical products worth $41.5M across 6 therapeutic categories.
TORRENT PHARMA INC — Pantoprazole Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Pantoprazole to TORRENT PHARMA INC?
Verified from 276 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TORRENT PHARMACEUTICALS LIMITED | $9.7M | 276 | 100.0% |
TORRENT PHARMA INC sources Pantoprazole from 1 verified Indian supplier based on 276 customs records. The primary supplier is TORRENT PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does TORRENT PHARMA INC Compare to Nearest Pantoprazole Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | APL SWIFT SERVICES (MALTA) LTD., | MALTA | $50.9M | 1,018 | $50.0K |
| 5 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $15.9M | 523 | $30.4K |
| 9 | TORRENT PHARMA INC ★ | UNITED STATES | $8.4M | 168 | $50.0K |
| 4 | EUGIA US LLC | UNITED STATES | $7.7M | 154 | $50.0K |
| 1 | MYLAN PHARMACEUTICALS INC, | UNITED STATES | $5.7M | 114 | $50.0K |
TORRENT PHARMA INC ranks #9 among 1,893 Pantoprazole importers from India. Average shipment value of $50.0K compared to the market average of $60.0K. The closest competitors by value are APL SWIFT SERVICES (MALTA) LTD., and YUSEN LOGISTICS BENELUX BELGIUM.
Where Does TORRENT PHARMA INC Import Pantoprazole To?
Destination countries from 276 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $9.7M | 276 | 100.0% |
TORRENT PHARMA INC imports Pantoprazole to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $9.7M.
What Pantoprazole Formulations Does TORRENT PHARMA INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| PANTOPRAZOLE SODIUM DR TABLETS USP 40 MG | $753.5K | 22 |
| PANTOPRAZOLE SODIUM DR TABLETS USP 40MG | $562.8K | 19 |
| OTHER-PANTOPRAZOLE SODIUM DR TABLETS USP | $456.8K | 10 |
| OTHER - PANTOPRAZOLE SODIUM DR TABLETS U | $323.4K | 9 |
| PANTOPRAZOLE SODIUM DR TABLETS USP 40MG(NDC NO.13668-429-90)(PANTOPRAZOLE 40MG)(NOS = 1X90 TAB) | $303.7K | 7 |
| OTHER-PANTOPRAZOLE SODIUM DR TABLETS USP40 MG (NDC NO. 13668-429-90) ( PANTOPRAZOLE 40MG ) NOS SIZE 1 X 90 TABLETS | $282.5K | 7 |
| PANTOPRAZOLE SODIUM DR TABLETS. USP 40 MG NDC NO13668-429-90 PANTOPRAZOLE 40MG NOS=1X90 TAB | $262.3K | 6 |
| OTHERS : PANTOPRAZOLE SODIUM DR TABLETS | $214.9K | 5 |
| PANTOPRAZOLE SODIUM DELAYED-RELEASE TABL | $203.1K | 9 |
| OTHERS : PANTOPRAZOLE SODIUM DR TABLETSUSP 40MG PANTOPRAZOLE SODIUM 40MG - 01NOS = SIZE 1x90 TABS | $184.3K | 4 |
TORRENT PHARMA INC imports 112 distinct Pantoprazole formulations from India. The top formulation is PANTOPRAZOLE SODIUM DR TABLETS USP 40 MG with 22 shipments worth $753.5K.
Regulatory Requirements: Importing Pantoprazole into United States
What TORRENT PHARMA INC and other importers must comply with to import Pantoprazole from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Pantoprazole
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Pantoprazole from India and How Much Does TORRENT PHARMA INC Import?
India exported $113.6M worth of Pantoprazole through 11,610 shipments from 744 suppliers to 154 countries, serving 1,893 buyers globally. TORRENT PHARMA INC imports $9.7M of this total, accounting for 0.6% of India's Pantoprazole exports with 276 shipments from UNITED STATES. This is verified from 276 customs shipment records covering 112 distinct formulations.
What Is the Average Order Value for TORRENT PHARMA INC's Pantoprazole Imports?
TORRENT PHARMA INC's average Pantoprazole order value is $35.3K per consignment, based on 276 shipments totaling $9.7M. TORRENT PHARMA INC is based in UNITED STATES and ranks #9 among all Pantoprazole importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Pantoprazole to TORRENT PHARMA INC?
TORRENT PHARMA INC sources Pantoprazole from 1 verified Indian supplier: TORRENT PHARMACEUTICALS LIMITED ($9.7M, 100.0%). This is based on 276 customs records.
How Does TORRENT PHARMA INC Compare to Other Pantoprazole Importers?
TORRENT PHARMA INC ranks #9 among 1,893 Pantoprazole importers from India with a 0.6% market share. The top 3 importers are APL SWIFT SERVICES (MALTA) LTD., ($50.9M), YUSEN LOGISTICS BENELUX BELGIUM ($15.9M), TORRENT PHARMA INC ($8.4M). TORRENT PHARMA INC processed 276 shipments from UNITED STATES.
About TORRENT PHARMA INC
TORRENT PHARMA INC imports 9 products worth $41.5M. Beyond Pantoprazole, top products include Citalopram, Isosorbide, Rosuvastatin, Nystatin, Escitalopram. View the complete TORRENT PHARMA INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pantoprazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pantoprazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: TORRENT PHARMA INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as TORRENT PHARMA INC's capped import value divided by total capped export value for Pantoprazole across all Indian exporters.
- 5.Verified Records: This page is backed by 276 individual customs records matching TORRENT PHARMA INC importing Pantoprazole, covering 112 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 154+ countries, 1,893+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pantoprazole Import Data for TORRENT PHARMA INC
Access order-level details, pricing data, supplier connections, and competitive analysis for TORRENT PHARMA INC's Pantoprazole imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TORRENT PHARMA INC
Full Company Profile →
9 products · $41.5M total trade · 6 categories
TORRENT PHARMA INC × Pantoprazole
Verified from customs records
Company Overview
Top Products by TORRENT PHARMA INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for TORRENT PHARMA INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pantoprazole. For current order-level data, contact TransData Nexus.